Table 3.
Condition and Recommended Drug | Dose* | Duration† | Comments‡ |
---|---|---|---|
days | |||
Erythema migrans | |||
| |||
Doxycycline (for patients ≥8 yr of age) | 200 mg/day (pediatric dose, 4 mg/kg/day) orally, divided into two doses per day | 14 (range, 10–21) | Do not use to treat children <8 yr of age or women who are pregnant or lactating; warn patient about exposure to sun, since photosensitivity rash occurs in 20–30% of patients; drug has good penetration into the central nervous system; patient should take drug with fluids to minimize nausea and gastrointestinal irritation; also effective against granulocytic anaplasmosis but not against babesiosis |
| |||
Amoxicillin | 1500 mg/day (pediatric dose, 50 mg/kg/day) orally, divided into three doses per day | 14 (range, 14–21) | This agent is not effective against granulocytic anaplasmosis or babesiosis |
| |||
Cefuroxime axetil | 1000 mg/day (pediatric dose, 30 mg/kg/day) orally, divided into two doses per day | 14 (range, 14–21) | This agent is not effective against granulocytic anaplasmosis or babesiosis |
| |||
Meningitis§ | |||
| |||
Ceftriaxone | 2 g/day (pediatric dose, 50–75 mg/kg/day) intravenously once per day | 14 (range, 10–28) | Treatment has risks associated with indwelling catheters, including infection, and can cause pseudolithiasis in the gallbladder |
| |||
Cefotaxime | 6 g/day (pediatric dose, 150– 200 mg/kg/day) intravenously, divided into doses administered every 8 hr | 14 (range, 10–28) | Treatment has risks associated with indwelling catheters, including infection |
| |||
Cranial-nerve palsy without clinical evidence of meningitis¶ | |||
| |||
Doxycycline (for patients ≥8 yr of age) | 200 mg/day (pediatric dose, 4 mg/kg/day) orally, divided into two doses per day | 14 (range, 14–21) | |
Amoxicillin | 1500 mg/day (pediatric dose, 50 mg/kg/day) orally, divided into three doses per day | 14 (range, 14–21) | See comments for drugs used to treat erythema migrans; there is not good evidence that treatment changes the outcome of facial palsy, but it does prevent additional sequelae of infection |
Cefuroxime axetil | 1000 mg/day (pediatric dose, 30 mg/kg/day) orally, divided into two doses per day | 14 (range, 14–21) | |
| |||
Carditis | |||
| |||
Same oral agents as for erythema migrans; same parenteral agents as for meningitis | Same doses as for oral and parenteral agents used to treat erythema migrans | 14 (range, 14–21) | Patients who are symptomatic should be hospitalized, monitored, and treated initially with a parenteral agent such as ceftriaxone; some patients with advanced heart block require a temporary pacemaker; after advanced block resolves, treatment may be completed with an oral agent |
| |||
Arthritis | |||
| |||
Same oral agents as for erythema migrans; same parenteral agents as for meningitis | Same doses as for oral and parenteral agents used to treat erythema migrans | 28 | Nonsteroidal antiinflammatory agents are often helpful as adjunctive treatment; for patients in whom arthritis persists or recurs, most experts recommend a second 28-day course of oral treatment; 14–28 days of parenteral treatment is an alternative |
For each drug, the maximum pediatric dose is the adult dose.
Recommendations are from the Infectious Diseases Society of America.
A reaction similar to the Jarisch–Herxheimer reaction may occur in the first 24 hours after treatment is begun.
There is evidence from Europe that treatment of meningitis with doxycycline administered orally is as good as parenteral treatment, although the species of borrelia that cause Lyme meningitis in Europe may be different from that in the United States.29
Doxycycline is preferable because of its good penetration into the central nervous system.